New England Compounding Center (NECC) is a compounding pharmacy founded in 1998. Based in Framingham, Massachusetts NECC is a family-run business owned by Barry J. Cadden, his wife, Lisa Cadden and her brother Gregory Conigliaro.
The company is the center of the New England Compounding Center meningitis outbreak scandal that started in May 21, 2012 and is linked to 44 deaths. NECC recalled more than 2,000 products after distributing 17,000 vials of methylprednisolone for injection contaminated with fungi to 23 states.
Food and Drug Administration (FDA) regulations dictate that compounding pharmacies like NECC combine, mix or alter ingredients only to create specific drugs for individual patients. Massachusetts state regulators reported NECC was licensed only to prepare individual patient prescriptions. The company, however, shipped drugs to multiple states, and may have been operating outside of their legal boundaries, authorities said. Doctors, hospitals and clinics had turned to compounding pharmacies like NECC because they often charge much lower prices than the major manufacturers.
On December 21, 2012, the company filed for Chapter 11 bankruptcy listing less than $2.34 million in debts. Following the bankruptcy, a Reuters investigation into financial filings revealed company payments exceeding $22 million to the top executives and private equity investors in 2012.
New England Compounding Center is a sister-company of Ameridose and Medical Sales Management.